本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

C4 Therapeutics, Inc.

2.72
+0.05001.87%
盤後2.740.0200+0.74%16:20 EDT
成交量:141.22萬
成交額:389.68萬
市值:1.94億
市盈率:-1.72
高:2.85
開:2.71
低:2.64
收:2.67
52周最高:7.22
52周最低:1.09
股本:7,117.08萬
流通股本:5,002.98萬
量比:1.33
換手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-1.5822
每股收益(LYR):-1.5181
淨資產收益率:-52.99%
總資產收益率:-22.80%
市淨率:1.11
市盈率(LYR):-1.79

資料載入中...

公司資料

公司名字:
C4 Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2015
員工人數:
110
公司地址:
490 Arsenal Way,Suite120,Watertown,Massachusetts,United States
郵編:
02472
電話:
傳真:
- -
簡介:
C4 Therapeutics, Inc.於2015年10月7日在特拉華州註冊成立。該公司是一家生物製藥公司,致力於利用人體對蛋白質水平的自然調節作用,開發新的治療性候選藥物,以靶向和破壞引起疾病的蛋白質來治療癌症,神經退行性疾病和其他疾病。

董事

名稱
職位
Andrew Hirsch
Director, President and Chief Executive Officer
Marc A. Cohen
Co-Founder, Executive Chairman, Director
Alain J. Cohen
Director
Bruce Downey
Director
Elena Prokupets
Director
Kenneth C. Anderson
Director
Malcolm Salter
Director

股東

名稱
職位
Andrew Hirsch
Director, President and Chief Executive Officer
William McKee
Chief Financial Officer
Adam Crystal
Chief Medical Officer
Jolie M. Siegel
Chief Legal Officer
Marc A. Cohen
Co-Founder, Executive Chairman, Director
Stewart Fisher
Chief Scientific Officer